Billerica, MA, United States of America

Syrena Fernandes

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Quanterix Corporation. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Syrena Fernandes: Innovator in Antibody Testing

Introduction

Syrena Fernandes is a notable inventor based in Billerica, MA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of antibody testing. Her innovative work has the potential to impact public health, especially in the context of infectious diseases.

Latest Patents

Syrena Fernandes holds 1 patent for her invention titled "Quantitative Antibody Test." This patent relates to methods and compositions, including kits, for quantitatively detecting an antibody of a subject to an infectious organism. Notably, her work includes methods for detecting human antibodies to the SARS-CoV-2 polypeptide or spike polypeptide. The applications of her invention are crucial for understanding immune responses to infections.

Career Highlights

Syrena is currently employed at Quanterix Corporation, where she continues to advance her research in antibody detection technologies. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative solutions in diagnostics.

Collaborations

Some of her coworkers include Andrew Ball and Lei Chang, who work alongside her at Quanterix Corporation. Their combined expertise fosters a collaborative environment that enhances the development of cutting-edge technologies.

Conclusion

Syrena Fernandes is a pioneering inventor whose work in quantitative antibody testing is making strides in the medical field. Her contributions are vital for improving diagnostic methods and understanding immune responses to infectious diseases.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…